ArticleTrials2025

The IC3 trial: protocol for a multicentre individually randomised controlled trial to compare a cirrhosis detection and hepatocellular carcinoma surveillance pathway vs usual care in Australian general practice for 45-75 years old with risk factors for chronic liver disease.

Leon A Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.